3i joins as new investor in Sweden's Carmel Pharma SLS Venture has signed an
agreement to sell about 23 % of Carmel Pharma to 3i, Europe's
leading venture capital and private equity company. ...
Demand Media Completes Over $100 Million in Funding The financing round was co-led by
3i and Oak Investment Partners, two leading venture capital
and private equity firms. Spectrum Equity Investors also ...
3i is a world leader in
venture capital and private equity. The company invests in a wide range of
opportunities from start-ups to buy-outs and buy-ins. The company focuses on
those opportunities with high growth potential and strong management. The
company’s function is to add value, bringing the extra capital, connections and
knowledge that will create successful independent businesses around the world.
The businesses, in which the company invests in, span more than 25 industry
sectors and over 150 of them have achieved stock market listings in the last ten
years. Just recently, 3i, announced that it has sold its 55% stake in Ezurio, a
leading manufacturer of Bluetooth solutions, in a $25m transaction to Laird
Technologies, Inc., a global leader in the design and supply of critical
components for advanced electronics and wireless products. The successful sale
of Ezurio sees 3i make a return of around three times money multiple on its
investment in the company.
|